NASDAQ:IDXG Interpace Biosciences (IDXG) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.01▼$1.1650-Day Range$4.75▼$10.4052-Week Range$2.57▼$10.42Volume2,030 shsAverage Volume2,522 shsMarket Capitalization$4.89 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsEarningsHeadlinesTrendsStock AnalysisCompetitorsEarningsHeadlinesTrends Get Interpace Biosciences alerts: Email Address Ad DarwinTop Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report About Interpace Biosciences Stock (NASDAQ:IDXG)Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.Read More Ad DarwinTop Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report IDXG Stock News HeadlinesJuly 21, 2024 | seekingalpha.comPDI: PIMCO Vs. BlackRock, 10 Big-Yield CEFs ComparedJuly 13, 2024 | seekingalpha.comPDI: Get In Before The Fed Pivots And Lock In A 14% YieldJuly 26, 2024 | Colonial Metals (Ad)Collapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.July 2, 2024 | seekingalpha.comPDI: I Sold A Chunk Of The Position But I Am Still Bullish On This Fund Going ForwardMay 9, 2024 | globenewswire.comInterpace Biosciences Announces First Quarter 2024 Financial and Business ResultsApril 3, 2024 | seekingalpha.comPDI Under $20 Exceeds A 13% Yield With Potential Upside On The HorizonMarch 7, 2024 | msn.comInterpace Biosciences announces preliminary Q4 revenue of $10.3MMarch 7, 2024 | globenewswire.comInterpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business ResultsJuly 26, 2024 | Colonial Metals (Ad)Collapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.March 1, 2024 | seekingalpha.comPDI: What Lurks Under The Hood Of PIMCO's Crown JewelFebruary 22, 2024 | benzinga.comInterpace Biosciences Stock (OTC:IDXG) Dividends: History, Yield and DatesJanuary 24, 2024 | seekingalpha.comPDI: 14% Yield, But Risks Are Rising (Rating Downgrade)January 9, 2024 | seekingalpha.comPDI Looks Like It Bottomed And Is Still Yielding Over 14%December 5, 2023 | seekingalpha.comPDI: Lag Likely To ContinueNovember 8, 2023 | finance.yahoo.comInterpace Biosciences Announces Record Third Quarter 2023 Financial and Business ResultsOctober 24, 2023 | seekingalpha.comPDI: Pain Could Be On The HorizonOctober 1, 2023 | seekingalpha.comPDI: Pricing Improves, Fundamentals Stay Poor, We UpgradeAugust 31, 2023 | seekingalpha.comPDI: 100 Big Yield CEFs, REITs, MLPs - These 3 Worth ConsideringSee More Headlines Receive IDXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Interpace Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Services Current SymbolNASDAQ:IDXG CUSIP69329V10 CIK1054102 Webwww.interpace.com Phone855-776-6419Fax862-207-7820Employees152Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$800,000.00 Net Margins2.26% Pretax Margin3.13% Return on Equity-2.03% Return on Assets9.06% Debt Debt-to-Equity RatioN/A Current Ratio0.50 Quick Ratio0.50 Sales & Book Value Annual Sales$40.21 million Price / Sales0.12 Cash Flow$0.63 per share Price / Cash Flow1.77 Book Value($14.16) per share Price / Book-0.08Miscellaneous Outstanding Shares4,370,000Free Float4,086,000Market Cap$4.89 million OptionableNot Optionable Beta0.67 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesDr. Thomas W. Burnell Ph.D. (Age 58)Pres, CEO & Director Comp: $425kMr. Thomas John Freeburg Ph.D. (Age 52)Chief Accounting Officer, CFO, Treasurer & Sec. Dr. Sydney D. FinkelsteinChief Scientific OfficerDr. Alidad Mireskandari M.B.A.Ph.D., Chief Devel. OfficerMr. Patrick KaneVP & Corp. ControllerKey CompetitorsVeracyteNASDAQ:VCYTNeoGenomicsNASDAQ:NEOLaboratory Co. of AmericaNYSE:LHQuest DiagnosticsNYSE:DGXDaVitaNYSE:DVAView All Competitors IDXG Stock Analysis - Frequently Asked Questions How were Interpace Biosciences' earnings last quarter? Interpace Biosciences, Inc. (NASDAQ:IDXG) announced its quarterly earnings results on Thursday, May, 9th. The business services provider reported $0.13 EPS for the quarter. The business services provider earned $10.27 million during the quarter. Interpace Biosciences had a negative trailing twelve-month return on equity of 2.03% and a net margin of 2.26%. What other stocks do shareholders of Interpace Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Interpace Biosciences investors own include Inovio Pharmaceuticals (INO), Novavax (NVAX), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Histogenics (HSGX), Johnson & Johnson (JNJ) and SCYNEXIS (SCYX). This page (NASDAQ:IDXG) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Interpace Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Interpace Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDXG Stock Alerts